0001062993-23-015060.txt : 20230718
0001062993-23-015060.hdr.sgml : 20230718
20230718203935
ACCESSION NUMBER: 0001062993-23-015060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230714
FILED AS OF DATE: 20230718
DATE AS OF CHANGE: 20230718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Godward Donna
CENTRAL INDEX KEY: 0001984167
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40228
FILM NUMBER: 231095411
MAIL ADDRESS:
STREET 1: C/O CARMELL THERAPEUTICS CORPORATION
STREET 2: 2403 SIDNEY STREET, SUITE 300
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALPHA HEALTHCARE ACQUISITION CORP III
CENTRAL INDEX KEY: 0001842939
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-494-3296
MAIL ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-07-14
0001842939
ALPHA HEALTHCARE ACQUISITION CORP III
CTCX
0001984167
Godward Donna
C/O CARMELL THERAPEUTICS CORPORATION
2403 SIDNEY STREET, SUITE 300
PITTSBURGH
PA
15203
0
1
0
0
Chief Quality Officer
0
Common Stock
2023-07-14
4
A
0
37296
A
37296
D
Stock Option (right to buy)
1.79
2023-07-14
4
A
0
2090
A
2027-06-20
Common Stock
2090
2090
D
Stock Option (right to buy)
2.27
2023-07-14
4
A
0
5318
A
2029-07-19
Common Stock
5318
5318
D
Stock Option (right to buy)
2.11
2023-07-14
4
A
0
119098
A
2031-09-23
Common Stock
119098
119098
D
Stock Option (right to buy)
2.11
2023-07-14
4
A
0
12309
A
2032-07-13
Common Stock
12309
12309
D
Stock Option (right to buy)
2.60
2023-07-14
4
A
0
12309
A
2032-12-15
Common Stock
12309
12309
D
On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each share of common stock of Legacy Carmell was exchanged for 0.06154 shares of common stock of Carmell Therapeutics Corporation.
Options are fully vested and exercisable.
Options to purchase 5,318 shares of common stock of Legacy Carmell granted on July 19, 2019, which vest as follows: 25% vested on July 19, 2020, July 19, 2021 and July 19, 2022 and the remaining 25% becomes vested on July 19, 2023.
Options to purchase 119,098 shares of common stock of Legacy Carmell granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
Options to purchase 12,309 shares of common stock of Legacy Carmell granted on July 13, 2023 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
Options to purchase 12,309 shares of common stock of Legacy Carmell granted on December 15, 2022, which vest as follows: 25% vesting on December 22, 2023 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation.
/s/ Randolph W. Hubbell, Attorney-in-Fact
2023-07-18